Financhill
Back

Intellia Therapeutics Vs. TransMedics Group Industry Stock Comparison

Sell
24

NTLA
Intellia Therapeutics

Last Price:
54.49
Seasonality Move:
7.17%
Sell
30

TMDX
TransMedics Group

Last Price:
39.78
Seasonality Move:
-17.01%
Sell
24
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $53.92. The Score for NTLA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
TransMedics Group (TMDX) is a Sell

Is TransMedics Group a Buy, Sell or Hold?

  • The current TransMedics Group [TMDX] share price is $41.68. The Score for TMDX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • TMDX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $53.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight selling pressure.

TMDX Stock Price Chart

What is TransMedics Group's stock price today?

  • The TransMedics Group share price today is $41.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TMDX is experiencing slight selling pressure.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.61 Sell
Relative Strength Index (14 RSI): 38.24 Sell
Chaikin Money Flow: -661550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.78 - 64.24) Sell
Bollinger Bands (100): (47.18 - 64.82) Sell

TMDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 33.71 Sell
Chaikin Money Flow: -20632 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.1 - 54.14) Sell
Bollinger Bands (100): (27.55 - 47.03) Buy

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.83 Sell
20-day SMA: 60.79 Sell
50-day SMA: 62.69 Sell
200-day SMA: 70.63 Sell
8-day EMA: 59.78 Sell
20-day EMA: 61 Sell
50-day EMA: 60.77 Sell
200-day EMA: 70.19 Sell

TMDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.91 Sell
20-day SMA: 50.87 Sell
50-day SMA: 45.55 Sell
200-day SMA: 28.48 Buy
8-day EMA: 46.79 Sell
20-day EMA: 48.72 Sell
50-day EMA: 45.39 Sell
200-day EMA: 33.6 Buy

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.16 per share, a decrease this year of $2.21 per share, and a decrease next year of $0.07 per share.

TransMedics Group Earnings Growth & TMDX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.15 per share, an increase this year of $0.01 per share, and an increase next year of $0.59 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

TransMedics Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):